Literature DB >> 6087871

Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease.

G Pizzolo, M Chilosi, G Semenzato, F Caligaris-Cappio, L Fiore-Donati, G Perona, G Janossy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6087871      PMCID： PMC1976791          DOI： 10.1038/bjc.1984.191

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  12 in total

1.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

2.  Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody.

Authors:  P C Beverley; R E Callard
Journal:  Eur J Immunol       Date:  1981-04       Impact factor: 5.532

3.  Detection of T and B cell antigens hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method.

Authors:  R Warnke; R Levy
Journal:  J Histochem Cytochem       Date:  1980-08       Impact factor: 2.479

4.  Discrepancy in expression ability of Tac antigen and Ia determinants defined by monoclonal antibodies on activated or cultured cord blood T lymphocytes.

Authors:  T Yokoi; T Miyawaki; A Yachie; S Ohzeki; N Taniguchi
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

5.  Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.

Authors:  S J Korsmeyer; W C Greene; J Cossman; S M Hsu; J P Jensen; L M Neckers; S L Marshall; A Bakhshi; J M Depper; W J Leonard; E S Jaffe; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

6.  Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas.

Authors:  H Stein; A Bonk; G Tolksdorf; K Lennert; H Rodt; J Gerdes
Journal:  J Histochem Cytochem       Date:  1980-08       Impact factor: 2.479

7.  Differential diagnosis of malignant lymphoma and nonlymphoid tumors using monoclonal anti-leucocyte antibody.

Authors:  G Pizzolo; J Sloane; P Beverley; J A Thomas; K F Bradstock; S Mattingly; G Janossy
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

8.  In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease.

Authors:  S Poppema; A K Bhan; E L Reinherz; M R Posner; S F Schlossman
Journal:  Blood       Date:  1982-02       Impact factor: 22.113

9.  Growth factors in Hodgkin's disease.

Authors:  R J Ford; S Mehta; F Davis; A L Maizel
Journal:  Cancer Treat Rep       Date:  1982-04

10.  Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia.

Authors:  F Caligaris-Cappio; M Gobbi; M Bofill; G Janossy
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307
View more
  9 in total

1.  Lectin activity as a marker for Hodgkin disease cells.

Authors:  E Paietta; R J Stockert; A G Morell; V Diehl; P H Wiernik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

2.  Rearrangement of immunoglobulin and T-cell receptor genes in Hodgkin's disease.

Authors:  M S Roth; B Schnitzer; E L Bingham; C E Harnden; D M Hyder; D Ginsburg
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

3.  Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.

Authors:  K Sheibani; C D Winberg; S van de Velde; D W Blayney; H Rappaport
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

4.  Immunoglobulin and T-cell receptor beta-chain gene rearrangement analysis of Hodgkin's disease: implications for lineage determination and differential diagnosis.

Authors:  D M Knowles; A Neri; P G Pelicci; J S Burke; A Wu; C D Winberg; K Sheibani; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  Peripheral blood and tumor-infiltrating mononuclear cell analysis in esophagus and head and neck cancer.

Authors:  P Lozac'h; P Corbeau; C Zabbe; J F Charles; P Youinou
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

6.  In situ quantification of T-cell subsets, NK-like cells and macrophages in Hodgkin's disease: quantity and quality of infiltration density depends on histopathological subtypes.

Authors:  G Gattringer; R Greil; T Radaszkiewicz; H Huber
Journal:  Blut       Date:  1986-07

7.  Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease.

Authors:  R N Damle; R J Tatake; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

8.  Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.

Authors:  G Pizzolo; M Chilosi; F Vinante; F Dazzi; M Lestani; G Perona; F Benedetti; G Todeschini; C Vincenzi; L Trentin
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

9.  Biological significance of soluble IL-2 receptor.

Authors:  C Caruso; G Candore; D Cigna; A T Colucci; M A Modica
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.